Circular 006/2021: Misuse of Drugs Act 1971: control of 3 benzodiazepines
A change to the Misuse of Drugs Act 1971 to control 3 benzodiazepines (flualprazolam, flunitrazolam and norfludiazepam) under Class C.
Documents
Details
This circular draws attention to the contents of Statutory Instruments (SIs), S.I. 2021/868 and 2021/897, which came into force at 00:01am on 18 August 2021:
- The Misuse of Drugs Act 1971 (Amendment) Order 2021 (S.I. 2021/868)
- The Misuse of Drugs and Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Regulations 2021 (S.I. 2021/897)
The Misuse of Drugs Act 1971 (Amendment) Order 2021 classifies flualprazolam, flunitrazolam and norfludiazepam as Class C drugs under paragraph 1(a) of Part 3 of Schedule 2 to the Misuse of Drugs Act 1971 (“the 1971 Act”).
Additionally, flualprazolam, flunitrazolam and norfludiazepam are placed into Part 1 of Schedule 1 to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 (“the 2015 Order”) and Schedule 1 to the Misuse of Drugs Regulations 2001 (“the 2001 Regulations”) as drugs which have no known legitimate medicinal use in the UK.